ID

26757

Descrizione

Study Part: Adverse Events Week 5 PK Visit (Visit 9). An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Keywords

  1. 23/10/17 23/10/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

23 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Adverse Events Week 5 PK Visit (Visit 9) Ropinirole Parkinson Disease 101468/165

Adverse Events Week 5 PK Visit (Visit 9)

ADVERSE EVENTS +4.5 HOURS
Descrizione

ADVERSE EVENTS +4.5 HOURS

Alias
UMLS CUI-1
C0877248
Patient Number
Descrizione

Patient Number

Tipo di dati

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Descrizione

Centre Number

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Visit Date
Descrizione

Visit Date

Tipo di dati

date

Alias
UMLS CUI [1]
C1320303
Has the subject experienced any Adverse Events?
Descrizione

Adverse Events

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Descrizione

Concomitant medications

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
ADVERSE EVENTS +12.5 HOURS
Descrizione

ADVERSE EVENTS +12.5 HOURS

Alias
UMLS CUI-1
C0877248
Has the subject experienced any Adverse Events?
Descrizione

Adverse Events

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Descrizione

Concomitant medications

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
ADVERSE EVENTS +24.5 HOURS
Descrizione

ADVERSE EVENTS +24.5 HOURS

Alias
UMLS CUI-1
C0877248
Has the subject experienced any Adverse Events?
Descrizione

Adverse Events

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Descrizione

Concomitant medications

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852

Similar models

Adverse Events Week 5 PK Visit (Visit 9)

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
ADVERSE EVENTS +4.5 HOURS
C0877248 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Item Group
ADVERSE EVENTS +12.5 HOURS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Item Group
ADVERSE EVENTS +24.5 HOURS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial